Abbot Financial Management’s Rubius Therapeutics, Inc RUBY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-452,345
| Closed | -$196K | – | 117 |
|
|
2022
Q3 | $196K | Sell |
452,345
-956,000
| -68% | -$414K | 0.14% | 107 |
|
|
2022
Q2 | $1.2M | Hold |
1,408,345
| – | – | 0.72% | 43 |
|
|
2022
Q1 | $7.76M | Sell |
1,408,345
-2,660
| -0.2% | -$14.7K | 3.79% | 3 |
|
|
2021
Q4 | $13.7M | Sell |
1,411,005
-770
| -0.1% | -$7.45K | 6.1% | 2 |
|
|
2021
Q3 | $25.2M | Hold |
1,411,775
| – | – | 11.48% | 1 |
|
|
2021
Q2 | $34.5M | Sell |
1,411,775
-2,725
| -0.2% | -$66.5K | 15.06% | 1 |
|
|
2021
Q1 | $37.5M | Buy |
1,414,500
+877,500
| +163% | +$23.3M | 17.01% | 1 |
|
|
2020
Q4 | $4.08M | Sell |
537,000
-26,500
| -5% | -$201K | 2.35% | 6 |
|
|
2020
Q3 | $2.82M | Hold |
563,500
| – | – | 1.83% | 16 |
|
|
2020
Q2 | $3.37M | Hold |
563,500
| – | – | 2.32% | 7 |
|
|
2020
Q1 | $2.51M | Hold |
563,500
| – | – | 2.04% | 12 |
|
|
2019
Q4 | $5.35M | Buy |
+563,500
| New | +$5.35M | 3.39% | 4 |
|